Onco-Innovations Appoints Dr. Islam Mohamed as Advisory Board Chair

Onco-Innovations Limited, a Canadian company specializing in cancer research, announced Dr. Islam Mohamed as the new Chair of its Scientific and Clinical Advisory Board. This strategic move underscores the company's dedication to advancing oncology solutions through expert-led research.

Dr. Mohamed, a seasoned radiation oncologist with over two decades of experience, brings a wealth of expertise in treating cancers such as lung and breast cancer. His roles at BC Cancer and involvement in clinical trials have significantly contributed to advancements in cancer treatment standards in Canada.

In addition to his clinical insights, Dr. Mohamed has extensive experience in the biotech sector, advising companies like Linax Technologies. His combined expertise as a clinician and entrepreneur positions him as a key asset for Onco-Innovations' research and development efforts.

The Advisory Board aims to guide Onco-Innovations' R&D priorities, fostering scientific collaboration and generating independent insights for decision-making. CEO Thomas O'Shaughnessy expressed enthusiasm for Dr. Mohamed's strategic role in driving the company's oncology initiatives.